TCI GENE Inc. (TPEX:6879)
Taiwan
· Delayed Price · Currency is TWD 33.25
-0.05 (-0.15%)
Mar 10, 2026, 1:34 PM CST
TCI GENE Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 324.73 | 347.54 | 333.86 | 424.02 | 432.22 | 192.95 |
| Revenue Growth (YoY) | -6.82% | 4.10% | -21.27% | -1.90% | 124.01% | - |
| Cost of Revenue | 137.79 | 143.47 | 159.24 | 180.66 | 192.79 | 73.71 |
| Gross Profit | 186.94 | 204.07 | 174.62 | 243.36 | 239.43 | 119.24 |
| Selling, General & Admin | 101.82 | 114.17 | 122.98 | 89.93 | 66.4 | 46.73 |
| Research & Development | 29.99 | 34.14 | 45.62 | 62.33 | 59.46 | 25.95 |
| Operating Expenses | 131.53 | 151.57 | 168.69 | 152.8 | 126.18 | 72.68 |
| Operating Income | 55.42 | 52.5 | 5.93 | 90.56 | 113.25 | 46.56 |
| Interest Expense | -0.87 | -0.5 | -1.18 | -0.85 | -0.84 | - |
| Interest & Investment Income | 36.2 | 37.81 | 9.67 | 3.64 | 0.23 | 0.07 |
| Earnings From Equity Investments | -10.3 | -9.35 | -5.86 | -3.45 | - | - |
| Currency Exchange Gain (Loss) | -1.63 | 0.05 | -0.07 | -0.69 | -0.24 | -0.25 |
| Other Non Operating Income (Expenses) | -0.14 | 0.17 | 0.22 | 0.68 | 5.96 | 1.59 |
| EBT Excluding Unusual Items | 78.69 | 80.68 | 8.71 | 89.89 | 118.36 | 47.96 |
| Gain (Loss) on Sale of Investments | -44.34 | -20.15 | - | - | -1.94 | - |
| Gain (Loss) on Sale of Assets | 7.09 | 7.03 | - | 0.24 | 0.01 | - |
| Other Unusual Items | - | - | 0.06 | - | - | - |
| Pretax Income | 42.03 | 67.56 | 8.78 | 90.13 | 116.44 | 47.96 |
| Income Tax Expense | 7.95 | 11.03 | -8.18 | 15.79 | 24.29 | 12.14 |
| Earnings From Continuing Operations | 34.08 | 56.53 | 16.95 | 74.34 | 92.14 | 35.82 |
| Minority Interest in Earnings | 1.72 | -0.21 | -5.28 | -2.19 | 0.31 | -0.07 |
| Net Income | 35.8 | 56.31 | 11.67 | 72.15 | 92.45 | 35.75 |
| Net Income to Common | 35.8 | 56.31 | 11.67 | 72.15 | 92.45 | 35.75 |
| Net Income Growth | 30.67% | 382.40% | -83.82% | -21.96% | 158.63% | - |
| Shares Outstanding (Basic) | 26 | 26 | 26 | 24 | 19 | 18 |
| Shares Outstanding (Diluted) | 27 | 27 | 26 | 25 | 20 | 19 |
| Shares Change (YoY) | 0.20% | 0.18% | 7.71% | 24.22% | 5.74% | - |
| EPS (Basic) | 1.35 | 2.13 | 0.44 | 2.95 | 4.84 | 1.94 |
| EPS (Diluted) | 1.35 | 2.12 | 0.44 | 2.93 | 4.67 | 1.91 |
| EPS Growth | 31.03% | 381.82% | -84.98% | -37.26% | 144.50% | - |
| Free Cash Flow | 94.55 | 54.4 | 15.46 | 96.4 | 96.39 | 31.81 |
| Free Cash Flow Per Share | 3.56 | 2.05 | 0.58 | 3.92 | 4.87 | 1.70 |
| Dividend Per Share | 2.000 | 2.000 | 1.000 | 2.000 | 2.028 | - |
| Dividend Growth | 100.00% | 100.00% | -50.00% | -1.36% | - | - |
| Gross Margin | 57.57% | 58.72% | 52.30% | 57.39% | 55.40% | 61.80% |
| Operating Margin | 17.07% | 15.11% | 1.78% | 21.36% | 26.20% | 24.13% |
| Profit Margin | 11.02% | 16.20% | 3.50% | 17.01% | 21.39% | 18.53% |
| Free Cash Flow Margin | 29.12% | 15.65% | 4.63% | 22.73% | 22.30% | 16.49% |
| EBITDA | 61.93 | 59.79 | 15.11 | 112.07 | 145.86 | 53.85 |
| EBITDA Margin | 19.07% | 17.20% | 4.53% | 26.43% | 33.75% | 27.91% |
| D&A For EBITDA | 6.52 | 7.29 | 9.18 | 21.51 | 32.61 | 7.3 |
| EBIT | 55.42 | 52.5 | 5.93 | 90.56 | 113.25 | 46.56 |
| EBIT Margin | 17.07% | 15.11% | 1.78% | 21.36% | 26.20% | 24.13% |
| Effective Tax Rate | 18.91% | 16.33% | - | 17.52% | 20.86% | 25.32% |
Source: S&P Capital IQ. Standard template. Financial Sources.